Evogene EVGN
NASDAQ EVGN
$0.56 +0.00 (+0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evogene (EVGN) Dividends Paid - Common (2020 - 2026)

Evogene (EVGN) posted Dividends Paid - Common of $8.5 million for Q1 2026, up 13.56% sequentially from $7.5 million in Q1 2025, and up 13.56% YoY from $7.5 million in Q1 2025.

Evogene (EVGN) Dividends Paid - Common (2020 - 2026) Analysis & Trends

Evogene has reported Dividends Paid - Common for 4 years, with the latest figure at $8.5 million in Q1 2026.

  • Quarterly Dividends Paid - Common rose 13.56% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.8 million (up 19.16% YoY) and the FY2025 annual result came in at $13.0 million, changed N/A from the prior year.
  • Dividends Paid - Common advanced to $8.5 million in Q1 2026 per EVGN's latest filing, from $7.5 million in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $8.5 million in Q1 2026 and troughed at $7.5 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Paid (Common) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 96.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 34.60 Mn
10 Evogene 4.38 Mn 4.38 Mn 204,000.00 8.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.51 Mn
Mar 31, 2026 8.51 Mn
Mar 31, 2025 7.50 Mn
Mar 31, 2025 7.50 Mn
Jun 30, 2021 4.11 Mn
Jun 30, 2021 4.11 Mn
Mar 31, 2021 38.64 Mn
Mar 31, 2021 38.64 Mn
Jun 30, 2020 -937,000.00
Jun 30, 2020 -937,000.00
Mar 31, 2020 32.01 Mn
Mar 31, 2020 32.01 Mn